Complex phenotypes in the haemoglobinopathies: Recommendations on screening and DNA testing

Pathology

Volumn 38, Issue 6, 2006, Pages 507-519

  Trent, Ronald J ^a   Webster, Boyd ^b   Bowden, Donald K ^c   Gilbert, Anne ^d   Ho, P Joy ^a   Lindeman, Robert ^e   Lammi, Ahti ^b   Rowell, John ^f   Hinchcliffe, Marcus ^a   Colley, Alison ^g   Wilson, Meredith ^b   Saleh, Mona ^h   Blackwell, Jennifer ^h   Petrou, Vicki ⁱ  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Children's Hospital Westmead   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

^f QUEENSLAND HEALTH   (Australia)

^g LIVERPOOL HOSPITAL   (Australia)

^h New South Wales Government   (Australia)

ⁱ Genetic Health Services Victoria   (Australia)

Author keywords

Complex; Gene gene interactions; Haemoglobinopathy; Screening; Thalassaemia; Variant

Indexed keywords

HEMOGLOBIN A2; HEMOGLOBIN S; DNA;

ALPHA THALASSEMIA; BETA THALASSEMIA; DNA SCREENING; DNA SEQUENCE; FETUS HYDROPS; GENE FREQUENCY; GENE INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HEMOGLOBINOPATHY; HETEROZYGOTE DETECTION; HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREVALENCE; REVIEW; SCREENING TEST; FEMALE; GENETIC SCREENING; GENETICS; MALE; METHODOLOGY; PEDIGREE; THALASSEMIA;

DNA; FEMALE; GENETIC SCREENING; HEMOGLOBIN, SICKLE; HEMOGLOBINOPATHIES; HETEROZYGOTE DETECTION; HUMANS; MALE; PEDIGREE; THALASSEMIA;

EID: 34247151197     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020601027634     Document Type: Article

References (28)

1. Working Party of the British Society of Haematology. Guideline. The laboratory diagnosis of haemoglobinopathies. Br J Haematol 1998; 101: 783-92.
2. British Committee for the Standardization in Haematology. Guidelines for the investigation of the α and β thalassaemia traits. J Clin Pathol 1994; 47: 289-95.
3. British Committee for the Standardization in Haematology. Guidelines for the fetal diagnosis of globin gene disorders. J Clin Pathol 1994; 47: 199-204.
4. National Health and Medical Research Council (NHMRC). How to Review the Evidence: Systematic Identification and Review of the Scientific Literature. Canberra: NHMRC, 2000. www.nhmrc.gov.au/publications/synopses/ cp65syn.htm (accessed Aug 2006).
5. Pennsylvania State University. Globin gene server. http://globin.cse.psu. edu/ (accessed Aug 2006).
6. Ho PJ, Hall GW, Luo LY, Weatherall DJ, Thein SL. Beta thalassaemia intermedia: is it possible consistently to predict phenotype from genotypes? Br J Haematol 1998; 100: 70-8.
7. th ed. Oxford: Blackwell Science, 2001; 553.
8. Bain BJ. Haemoglobinopathy Diagnosis. Oxford: Blackwell Science, 2001; 84.
9. 2 (type 2) β thalassaemia in Greece. Hematol Pathol 1994; 8: 25-34.
10. th ed. Oxford: Blackwell Science, 2001; 240.
11. Berdoukas VA, Webster BH, Raddatz B. Community-initiated screening programme for beta-thalassaemia trait. Med J Aust 1983; 2: 129-31.
12. th ed. Oxford: Blackwell Science, 2001; 166.
13. Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev 2003; 17: 43-53.
14. Forget BG. Molecular basis of hereditary persistence of fetal hemoglobin. Ann NY Acad Sci 1998; 850: 38-44.
15. Kanavakis E, Papassotiriou I, Karagiorga M, et al. Phenotypic and molecular diversity of haemoglobin H disease: a Greek experience. Br J Haematol 2000; 111: 915-23.
16. th ed. Oxford: Blackwell Science, 2001; 522.
17. Chui DHK, Waye JS. Hydrops fetalis caused by α thalassemia: an emerging health care problem. Blood 1998; 91: 2213-22.
18. Chui DHK, Fucharoen S, Chan Vl. Hemoglobin H disease: not necessarily a benign disorder. Blood 2003; 101: 791-800.
19. Charoenkwan P, Wanapirak C, Thanarattanakorn P, et al. Hemoglobin E levels in double heterozygotes of hemoglobin E and SEA-type α-thalassemia. SE Asian J Trop Med Public Health 2005; 36: 467-70.
20. Chan LC, Ma SK, Chan AYY, et al. Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80fL in areas with a high prevalence of thalassaemia? J Clin Pathol 2001; 54: 317-20.
21. National Pathology Accreditation Advisory Council (NPAAC). Draft publication title: Standards and Guidelines for the Estimation of Uncertainty of Measurement. Canberra: NPAAC, 2006. http://www.health.gov.au/internet/ wcms/Publishing.nsf/Content/health-npaac-publication.htm (accessed Aug 2006).
22. Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev 2001; 2: 245-55.
23. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. Thalassemia. Hematology Am Soc Hematol Educ Program 2004; 14-34.
24. Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J, editors. Guidelines for the Clinical Management of Thalassaemia. Nicosia, Cyprus: Thalassaemia International Federation, 2000. http://www.thalassaemia.org.cy/ Publications.htm (accessed Aug 2006).
25. Thein SL. Genetic modifiers of β thalassemia. Haematologica 2005; 90: 649-60.
26. Rund D, Rachmilewitz E. β Thalassemia. N Engl J Med 2005; 353: 1135-46.
27. Steinberg MH. Compound heterozygous and other sickle haemoglobinopathies. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge: Cambridge University Press, 2001; 787-802.
28. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucl Acids Res 2002; 30: e57.